# Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

> **NCT00120198** · PHASE2 · TERMINATED · sponsor: **Geriatric Oncology Consortium** · enrollment: 50 (estimated)

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** CDOP plus rituximab

## Key facts

- **NCT ID:** NCT00120198
- **Lead sponsor:** Geriatric Oncology Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** slow accrual
- **Last updated:** 2007-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120198, "Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00120198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*